DNM1L and diabetic kidney disease: In addition, the podocyte-specific knockdown of DRP1 in the DKD mouse model improved its mitochondrial structure function and adaptability [611], and pharmacological inhibition of DRP1 in podocytes reduced mitochondrial fission to stabilize mitochondria thereby improving DKD [611, 612].